Evidence map

TrialJournal of diabetes science and technology2015

Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.

Jeffrey H Burton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25802471